Reduced attention in mice overproducing corticotropin-releasing hormone

Behavioural Brain Research

Volumn 142, Issue 1-2, 2003, Pages 69-79

  Van Gaalen, M M ^a,c   Stenzel Poore, M ^b   Holsboer, F ^a   Steckler, T ^a,d  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Attention; Corticotropin releasing hormone; CRH; Mouse; Overexpressor; Transgenic

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; DIAZEPAM;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DISCRIMINATION LEARNING; HORMONE SYNTHESIS; INSTRUMENTAL CONDITIONING; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; STIMULUS RESPONSE; TASK PERFORMANCE; TRAINING; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTI-ANXIETY AGENTS; ATTENTION; CONDITIONING, CLASSICAL; CORTICOTROPIN-RELEASING HORMONE; DIAZEPAM; DISCRIMINATION LEARNING; GENE EXPRESSION; MALE; MICE; MICE, TRANSGENIC; REACTION TIME;

EID: 0037602113     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00381-9     Document Type: Article

References (52)

1. Behan D.P., Heinrichs S.C., Troncoso J.C., Liu X.J., Kawas C.H., Ling N.et al. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature. 378:1995;284-287.
2. Bittencourt J.C., Sawchenko P.E. Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J. Neurosci. 20:2000;1142-1156.
3. Burkhart M.A., Thomas D.G. Event-related potential measures of attention in moderately depressed subjects. Electroencephalogr. Clin. Neurophysiol. 88:1993;42-50.
4. Bushnell P.J. Overt orienting in the rat: parametric studies of cued detection of visual targets. Behav. Neurosci. 109:1995;1095-1105.
5. Bushnell P.J. Behavioral approaches to the assessment of attention in animals. Psychopharmacology. 138:1998;231-259.
6. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
7. Cole S.O., Michaleski A. Dose-dependent impairment in the performance of a go-no go successive discrimination by chlordiazepoxide. Psychopharmacology. 88:1986;184-186.
8. Day J.C., Koehl M., Deroche V., Le Moal M., Maccari S. Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. J. Neurosci. 18:1998a;1886-1892.
9. Day J.C., Koehl M., Le Moal M., Maccari S. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J. Neurochem. 71:1998;622-629.
10. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 20:1995;789-819.
11. Dudchenko P., Gordon B.M., Sarter M. Effects of benzodiazepine receptor ligand on simultaneous visual discriminations of variable difficulty. J. Psychopharmacol. 8:1994;141-147.
12. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
13. Garcia-Rill E. The pedunculopontine nucleus. Prog. Neurobiol. 36:1991;363-389.
14. Heinrichs S.C., Joppa M. Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav. Brain Res. 122:2001;43-50.
15. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E., Bloom F.E., Koob G.F.et al. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74:1996;303-311.
16. Heinrichs S.C., Vale E.A., Lapsansky J., Behan D.P., McClure L.V., Ling N.et al. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides. 18:1997;711-716.
17. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33:1999;181-214.
18. Holsboer F., Spengler D., Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res. 93:1992;385-417.
19. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 11:1999;2813-2823.
20. Kling M.A., Roy A., Doran A.R., Calabrese J.R., Rubinow D.R., Whitfield H.J.et al. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J. Clin. Endocrinol. Metab. 72:1991;260-271.
21. Koob G.F., Cole B.J., Swerdlow N.R., Le Moal M., Britton K.T. Stress, performance, and arousal: focus on CRF. NIDA Res. Monogr. 97:1990;163-176.
22. Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443:1988;63-69.
23. Lemelin S., Baruch P., Vincent A., Everett J., Vincent P. Distractibility and processing resource deficit in major depression. Evidence for two deficient attentional processing models. J. Nerv. Ment. Dis. 185:1997;542-548.
24. Marston H.M. Analysis of cognitive function in animals, the value of SDT. Brain Res. Cogn. Brain Res. 3:1996;269-277.
25. McGaughy J., Turchi J., Sarter M. Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine. Psychopharmacology. 115:1994;213-220.
26. McNaughton N. Chlordiazepoxide and successive discrimination: different effects on acquisition and performance. Pharmacol. Biochem. Behav. 23:1985;487-494.
27. Mialet J.P., Pope H.G., Yurgelun-Todd D. Impaired attention in depressive states: a non-specific deficit? Psychol. Med. 26:1996;1009-1020.
28. Mirsky AF, Rosvod HE. The use of psychoactive drugs as a neuropsychological tool in studies of attention in man. In: Uhr L, Miller JG, editors. Drugs and behaviour. New York: Wiley; 1960. p. 375-92.
29. Muir J.L., Dunnett S.B., Robbins T.W., Everitt B.J. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp. Brain Res. 89:1992;611-622.
30. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
31. Muir J.L., Everitt B.J., Robbins T.W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb. Cortex. 6:1996;470-481.
32. Muir J.L., Robbins T.W., Everitt B.J. Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms. Psychopharmacology. 107:1992;541-550.
33. Overton P., Dean P. Detection of visual stimuli after lesions of the superior colliculus in the rat; deficit not confined to the far periphery. Behav. Brain Res. 31:1988;1-15.
34. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:1991;425-473.
35. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4192-4196.
36. Radulovic J., Ruhmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19:1999;5016-5025.
37. Rief W., Hermanutz M. Responses to activation and rest in patients with panic disorder and major depression. Br. J. Clin. Psychol. 35:1996;605-616.
38. Robbins T.W., Everitt B.J., Marston H.M., Wilkinson J., Jones G.H., Page K.J. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res. 35:1989;221-240.
39. Robbins TW, Muir JL, Killcross S, Pretsell DO. Assessing attention and stimulus control in the rat. In: Saghal A, editor. Behavioural neuroscience: a practical approach, vol. 1. Oxford: Oxford University Press; 1993. p. 165-84.
40. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L.et al. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology. 110:1993;395-401.
41. Sauvage M., Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei - potential implication for arousal and attention. Neuroscience. 104:2001;643-652.
42. Steckler T. Using signal detection methods for analysis of operant performance in mice. Behav. Brain Res. 125:2001;237-248.
43. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiatr. 46:1999;1480-1508.
44. Steckler T., Inglis W., Winn P., Sahgal A. The pedunculopontine tegmental nucleus: a role in cognitive processes? Brain Res. - Brain Res. Rev. 19:1994;298-318.
45. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:1992;3378-3386.
46. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
47. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
48. Van Gaalen M.M., Reul J.M.H.M., Gesing A., Stenzel-Poore M., Holsboer F., Steckler T. Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a 5-HT1A receptor challenge. Genes Brain Behav. 1:2002;174-177.
49. Van Gaalen M.M., Stenzel-Poore M.P., Holsboer F., Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 15:2002;2007-2015.
50. Wilkinson R.T. Interaction of noise with knowledge of results and sleep depreviation. J. Exp. Psychol. 66:1963;332-337.
51. Williams R.A., Hagerty B.M., Cimprich B., Therrien B., Bay E., Oe H. Changes in directed attention and short-term memory in depression. J. Psychiatr. Res. 34:2000;227-238.
52. Yerkes RM, Dodson JD. The relation of strength of stimulus to rapidity of habit-formation. J Comp Neurol Psychol 1908;459-82.